(Allergan plc)

	AGN latest price $161.7837 (1.52%) ($155.5870 - $161.9408) on Tue. Apr. 3, 2018.
	Trend Analysis and Forecast
Average Daily Percentage Swing	2.08% (three month average)
RSI	53
Latest Price	$161.7837(1.52%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.6% a day on average for past five trading days.
Weekly Trend	AGN declines -0.5% a week on average for past two weeks.
Market Behavior	Broad based rally for large cap. Broad based rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(49%)    XBI(47%)    ARKG(45%)    SPY(45%)
Factors Impacting AGN price	AGN will decline at least -1.04% in a week (0% probabilities).   VIXM(-28%)    TLT(-20%)    UUP(-18%)    DIA(-7%)    GDXJ(-6%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-1.04% (StdDev 2.08%)
Hourly BBV	0 ()
Intraday Trend	0.9%

5 Day Moving Average	$161.31(0.29%)
10 Day Moving Average	$160.21(0.98%)
20 Day Moving Average	$159.05(1.72%)
To recent high	-12.1%
To recent low	14.4%
Market Cap	$53.34b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed